SEMERARO, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 2.640
AS - Asia 878
EU - Europa 859
SA - Sud America 212
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 47
OC - Oceania 2
Totale 4.724
Nazione #
US - Stati Uniti d'America 2.596
SG - Singapore 369
IT - Italia 220
CN - Cina 205
BR - Brasile 166
DE - Germania 132
RU - Federazione Russa 120
HK - Hong Kong 112
SE - Svezia 85
FR - Francia 80
FI - Finlandia 67
VN - Vietnam 55
GB - Regno Unito 40
UA - Ucraina 33
IN - India 27
BE - Belgio 20
CA - Canada 20
AR - Argentina 19
BD - Bangladesh 18
CI - Costa d'Avorio 17
TR - Turchia 15
MX - Messico 13
NL - Olanda 13
ZA - Sudafrica 13
ID - Indonesia 12
IE - Irlanda 12
IQ - Iraq 11
JP - Giappone 8
PL - Polonia 8
CO - Colombia 7
DK - Danimarca 7
JO - Giordania 6
MY - Malesia 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
ES - Italia 5
PH - Filippine 5
PK - Pakistan 5
VE - Venezuela 5
AT - Austria 4
PY - Paraguay 4
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
AO - Angola 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.639
Città #
Fairfield 306
Ashburn 272
Singapore 205
Woodbridge 195
Houston 178
Chandler 163
Seattle 120
San Jose 118
Hong Kong 111
Cambridge 100
Wilmington 94
Jacksonville 86
Milan 73
Nyköping 73
Ann Arbor 70
Beijing 62
Bari 47
Helsinki 40
Council Bluffs 38
New York 36
Dallas 33
Los Angeles 32
Roxbury 31
Lauterbourg 29
Lawrence 28
Santa Clara 25
Ho Chi Minh City 22
Rome 21
Brussels 20
Des Moines 18
Inglewood 18
Nanjing 18
Abidjan 17
São Paulo 17
Grafing 15
Strasbourg 15
Columbus 14
Princeton 14
Brooklyn 13
Figino 13
Frankfurt am Main 13
Boardman 12
Dublin 12
Phoenix 12
San Diego 12
Chicago 10
Hanoi 10
London 10
Munich 10
Atlanta 9
Hebei 9
Moscow 9
Johannesburg 8
Nanchang 8
Rijnsburg 8
Tokyo 8
Boston 7
Mexico City 7
Paris 7
Charlotte 6
Jakarta 6
Orem 6
Shenyang 6
Tianjin 6
Turin 6
Warsaw 6
Amman 5
Baghdad 5
Belo Horizonte 5
Changsha 5
Duque de Caxias 5
Nuremberg 5
San Francisco 5
Secaucus 5
The Dalles 5
Ankara 4
Brno 4
Buffalo 4
Kuala Lumpur 4
Montreal 4
Naples 4
Poplar 4
Redwood City 4
Rio de Janeiro 4
Salt Lake City 4
Shanghai 4
Stockholm 4
Toronto 4
Washington 4
Aarhus 3
Addis Ababa 3
Amsterdam 3
Bethlehem 3
Boydton 3
Brasília 3
Caracas 3
Dearborn 3
Espoo 3
Hải Dương 3
Istanbul 3
Totale 3.157
Nome #
Coagulopathy of Acute Sepsis 226
Platelet drop and fibrinolytic shutdown in patients with sepsis 217
Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives and dabigatran. 199
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots 192
FVIII/VWF complex displays a greater pro-hemostatic activity than FVIII preparations devoid of VWF. Study in plasma and cell-based models 185
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation 179
Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles 178
Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease 175
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis 159
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 154
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor 151
Microarray data and pathway analyses of peripheral blood mononuclear cells from healthy subjects after a three weeks grape-rich diet 149
Platelets and fibrinolysis 148
Gene expression signature induced by grape intake in healthy subjects reveals wide-spread beneficial effects on peripheral blood mononuclear cells 148
Endothelial cells in the bone marrow of patients with multiple myeloma 139
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma 137
Hyperprothrombinemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis 137
Sepsis, thrombosis and organ dysfunction 136
Low D-dimer levels in sepsis: Good or bad? 132
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots 131
Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way 127
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential 123
Diversi fattori contribuiscono alla ipofibrinolisi nei bambini obesi 122
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. 121
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 118
Evidence that fibrynolitic changes in paediatric obesity translate in a hypofibrinolytic state. Relative contribution of TAFI and PAI-1 118
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood 115
Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses 101
TISSUE FACTOR-EXPRESSING MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TAFI-MEDIATED MECHANISM, AND MAKE CLOTS RESISTANT TO HEPARINS 99
Monoclonal antibodies targeting the antifibrinolytic activity of activated TAFI but not the anti-inflammatory activity on osteopontin and C5a 91
Angiogenic endothelial cells within the bone marrow of multiple myeloma. A phenotypic and functional assessment 84
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy 70
The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of LMWHs 62
Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A 48
Influence of Emicizumab on protein C-mediated clotting regulation 46
Extracellular histones promote retraction and impair lysability of platelet-rich clots 7
Totale 4.724
Categoria #
all - tutte 18.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022208 0 0 3 5 3 14 22 14 12 23 48 64
2022/2023422 61 50 27 41 32 44 6 57 88 1 11 4
2023/2024113 12 27 1 14 6 17 2 10 0 1 6 17
2024/2025661 25 2 42 39 9 53 70 87 21 16 116 181
2025/20261.458 162 77 101 195 177 64 173 43 156 104 38 168
2026/2027225 138 47 40 0 0 0 0 0 0 0 0 0
Totale 4.724